Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets

European Neuropsychopharmacology

Volumn 23, Issue 10, 2013, Pages 1182-1189

  Gong, Yunguo ^a   Wu, Chao N ^a   Xu, Jiawei ^a   Feng, Guoyin ^b   Xing, Q H ^a,b   Fu, W ^a   Li, Chong ^d   He, L ^a,b,c   Zhao, X Z ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Chinese Academy of Sciences   (China)

^d SOUTHWEST UNIVERSITY   (China)

Author keywords

3' untranslated regions (3' UTRs); Binding site; MiRNA; Schizophrenia; SNP

Indexed keywords

MESSENGER RNA; MICRORNA;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING SITE; CASE CONTROL STUDY; CELL STRAIN HEK293; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POLYMERASE CHAIN REACTION; POPULATION RISK; PRIORITY JOURNAL; RNA BINDING; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

3′ UNTRANSLATED REGIONS (3′ UTRS); BINDING SITE; MIRNA; SCHIZOPHRENIA; SNP;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHINA; COHORT STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GABA-A; RGS PROTEINS; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 84884288739     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.12.002     Document Type: Article

References (49)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40(7):827-834.
2. Berezikov E., Thuemmler F., van Laake L.W., Kondova I., Bontrop R., Cuppen E., Plasterk R.H. Diversity of microRNAs in human and chimpanzee brain. Nat. Genet. 2006, 38(12):1375-1377.
3. Bowden N.A., Scott R.J., Tooney P.A. Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia. Schizophr. Res. 2006, 89(1-3):165-168.
4. Brendle A., Lei H., Brandt A., Johansson R., Enquist K., Henriksson R., Hemminki K., Lenner P., Forsti A. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 2008, 29(7):1394-1399.
5. Burmistrova O.A., Goltsov A.Y., Abramova L.I., Kaleda V.G., Orlova V.A., Rogaev E.I. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc) 2007, 72(5):578-582.
6. Baev V., Daskalova E., Minkov I. Computational identification of novel microRNA homologs in the chimpanzee genome. Comput. Biol. Chem. 2009, 33(1):62-70.
7. Bray N.J., Buckland P.R., Williams N.M., Williams H.J., Norton N., Owen M.J., O'Donovan M.C. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am. J. Hum. Genet. 2003, 73(1):152-161.
8. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., O'Donovan M.C. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet. 2005, 14(14):1947-1954.
9. Campbell D.B., Ebert P.J., Skelly T., Stroup T.S., Lieberman J., Levitt P., Sullivan P.F. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Biol. Psychiatry 2008, 63(1):32-41.
10. Chan R.C., Chen R.Y., Chen E.Y. The differential clinical and neurocognitive profiles of COMT SNP rs165599 genotypes in schizophrenia. J. Int. Neuropsychol. Soc. 2005, 11(2):202-204.
11. Chen K., Song F., Calin G.A., Wei Q., Hao X., Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008, 29(7):1306-1311.
12. Duan R., Pak C., Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum. Mol. Genet. 2007, 16(9):1124-1131.
13. Erdely H.A., Tamminga C.A., Roberts R.C., Vogel M.W. Regional alterations in RGS4 protein in schizophrenia. Synapse 2006, 59(8):472-479.
14. Fang M., Wang J., Zhang X., Geng Y., Hu Z., Rudd J.A., Ling S., Chen W., Han S. The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. Toxicol. Lett. 2012, 209(1):94-105.
15. Funke B., Malhotra A.K., Finn C.T. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav. Brain Funct. 2005, 1:19.
16. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2004, D154-D158. (2008, 36 (Database issue)).
17. Gu Z., Jiang Q., Yan Z. RGS4 modulates serotonin signaling in prefrontal cortex and links to serotonin dysfunction in a rat model of schizophrenia. Mol. Pharmacol. 2007, 71(4):1030-1039.
18. Hansen T., Olsen L., Lindow M., Jakobsen K.D., Ullum H., Jonsson E., Andreassen O.A., Djurovic S., Melle I., Agartz I. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007, 2(9):e873.
19. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122(Pt 4):593-624.
20. John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C., Marks, D.S. Human MicroRNA targets. PLoS Biol. 2 (11), e363.
21. Kahler A.K., Djurovic S., Kulle B., et al. Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(7):1089-1100.
22. Neuropsychopharmacology: The Fifth Generation of Progress 2002, American College of Neuropsychopharmacology. fifth ed. L. Kenneth, D.C. Davis, T. Coyle, C. Nemeroff (Eds.).
23. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37(5):495-500.
24. Kruger J., Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006, 34:W451-W454. (Web Server issue).
25. Kocerha J., Faghihi M.A., Lopez-Toledano M.A., Huang J., Ramsey A.J., Caron M.G., Sales N., Willoughby D., Elmen J., Hansen H.F. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(9):3507-3512.
26. Miyamoto S., LaMantia A.S., Duncan G.E., Sullivan P., Gilmore J.H., Lieberman J.A. Recent advances in the neurobiology of schizophrenia. Mol. Interv. 2003, 3(1):27-39.
27. Mellios N., Huang H.S., Grigorenko A., Rogaev E., Akbarian S. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum. Mol. Genet. 2008, 17(19):3030-3042.
28. Mishra P.J., Humeniuk R., Longo-Sorbello G.S., Banerjee D., Bertino J.R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(33):13513-13518.
29. Need A.C., Ge D., Weale M.E., Maia J., Feng S., Heinzen E.L., Shianna K.V., Yoon W., Kasperaviciute D., Gennarelli M. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 2009, 5(2):e1000373.
30. Ohtsuki T., Sakurai K., Dou H., Toru M., Yamakawa-Kobayashi K., Arinami T. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol. Psychiatry 2001, 6(2):211-216.
31. Palo O.M., Antila M., Silander K., et al. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum. Mol. Genet. 2007, 16(20):2517-2528.
32. Perkins D.O., Jeffries C.D., Jarskog L.F., Thomson J.M., Woods K., Newman M.A., Parker J.S., Jin J., Hammond S.M. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007, 8(2):R27.
33. Plomin R., Owen M.J., McGuffin P. The genetic basis of complex human behaviors. Science 1994, 264(5166):1733-1739.
34. Sethupathy Praveen, Megraw Molly, Hatzigeorgiou G. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods 2006, 3(11):881.
35. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., Coyle J.T. Neurobiology of schizophrenia. Neuron 2006, 52(1):139-153.
36. Rusinov V., Baev V., Minkov I.N., Tabler M. MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res. 2005, 33:W696-W700. (Web Server issue).
37. Riley B., Thiselton D., Maher B.S., Bigdeli T., Wormley B., McMichael G.O., Fanous A.H., Vladimirov V., O'Neill F.A., Walsh D. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol. Psychiatry 2010, 15(1):29-37.
38. Schwab S.G., Knapp M., Sklar P., et al. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol. Psychiatry 2006, 11(9):837-846.
39. Severinsen J.E., Bjarkam C.R., Kiaer-Larsen S., et al. Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. Mol. Psychiatry 2006, 11(12):1126-1138.
40. Saetrom P., Biesinger J., Li S.M., Smith D., Thomas L.F., Majzoub K., Rivas G.E., Alluin J., Rossi J.J., Krontiris T.G., et al. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res. 2009, 69(18):7459-7465.
41. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15(2):97-98.
42. Shirts B.H., Wood J., Yolken R.H., Nimgaonkar V.L. Association study of IL10, IL1β, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1β. Schizophrenia Research 2006, 88(1-3):235-244.
43. Shifman S., Bronstein M., Sternfeld M., et al. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 2002, 71(6):1296-1302.
44. Takao T., Tachikawa H., Kawanishi Y., Mizukami K., Asada T. CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: a preliminary study. Eur. Neuropsychopharmacol. 2007, 17(4):273-276.
45. Xie L., Ju G.Z., Liu S.Z., Shi J.P., Yu Y.Q., Wei J. Searching for a schizophrenia susceptibility gene in the 22q11 region. Biomed. Environ. Sci. 2005, 18(1):31-35.
46. Yue W.H., Zhang H.D., Tang F.L., et al. Association study of the regulator of G-protein signaling 4(RGS4) polymorphisms with schizophrenia. Chin. Ment. Health J. 2007, 21(3):181.
47. Zhang, J.H., Yue, W.H., Zhang, X.S., 2008. Multilocus analysis of case-control data to schizophrenia based on measures of information discrepancy. In: Proceedings of the 7th International Symposium on Operations Research and its Applications (ISORA'08), October 31-November 3. Lijiang, China.
48. Zheng F., Adelsberger H., Muller M.R., Fritschy J.M., Werner S., Alzheimer C. Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior. Mol. Psychiatry 2009, 14(3):332-346.
49. Zhu Y., Kalbfleisch T., Brennan M.D., Li Y. A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophr. Res. 2009, 109(1-3):86-89.